Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROactive pioglitazone Clinical Trial In macro Vascular Events): a randomised controlled trial
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F05%3A00009452" target="_blank" >RIV/00216208:11110/05:00009452 - isvavai.cz</a>
Alternative codes found
RIV/00064165:_____/05:00001213
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROactive pioglitazone Clinical Trial In macro Vascular Events): a randomised controlled trial
Original language description
Secondary prevention of macrovascular events, diabetes mellitus type 2, PROactive Study
Czech name
Sekundární prevence makrovaskulárních příhod u pacientů s diabetem 2.typu ve studii PROACTIVE: randomizovaná kontrolovaná studie
Czech description
Sekundární prevence makrovaskulárních příhod, diabet 2.typu, PROACTIV studie
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FB - Endocrinology, diabetology, metabolism, nutrition
OECD FORD branch
—
Result continuities
Project
—
Continuities
V - Vyzkumna aktivita podporovana z jinych verejnych zdroju
Others
Publication year
2005
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Lancet
ISSN
0140-6736
e-ISSN
—
Volume of the periodical
366
Issue of the periodical within the volume
9493
Country of publishing house
GB - UNITED KINGDOM
Number of pages
11
Pages from-to
1279-1289
UT code for WoS article
—
EID of the result in the Scopus database
—